Imaging Findings in Cirrhotic Liver: Pearls and Pitfalls for Diagnosis of Focal Benign and Malignant Lesions
Authors:
- Xiaoyang LiuXLXiaoyang Liu
- Stephanie B. M. TanSTStephanie B. M. Tan
- Muhammad O. AwiwiMAMuhammad O. Awiwi
- Hyun-Jung JangHJHyun-Jung Jang
- Victoria ChernyakVCVictoria Chernyak
- Kathryn J. FowlerKFKathryn J. Fowler
- Akram M. ShaabanASAkram M. Shaaban
- Claude B. SirlinCSClaude B. Sirlin
- Alessandro FurlanAFAlessandro Furlan
- Robert M. MarksRMRobert M. Marks
- Khaled M. ElsayesKEKhaled M. Elsayes
- 1 September 2023
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (9) , e230043
Abstract
Cirrhosis is the end stage of chronic liver disease and causes architectural distortion and perfusional anomalies. It is a major risk factor for developing hepatocellular carcinoma (HCC). Common disease entities in noncirrhotic livers, such as hemangiomas, can be rare in cirrhotic livers, and benign entities such as confluent hepatic fibrosis and focal nodular hyperplasia-like lesions may mimic the appearance of malignancies,. HCC usually has typical imaging characteristics, such as the major features established by the Liver Imaging Reporting and Data System. However, HCC can also have a spectrum of atypical or uncommon appearances, such as cystic HCC, hypovascular HCC, or macroscopic fat-containing HCC. HCCs with certain genetic mutations such as CTNNB-1-mutated HCC can harbor unique imaging features not seen in other types of HCC. In addition, malignancies that are less common than HCC, such as cholangiocarcinoma and metastases, which can be difficult to differentiate, can still occur in cirrhotic livers. Atypical imaging features of benign and malignant lesions can be challenging to accurately diagnose. Therefore, familiarity with these features and an understanding of the prevalence of disease entities in cirrhotic livers are key in the daily practice of radiologists for evaluation of cirrhotic livers. The authors illustrate the typical and atypical features of benign and malignant lesions in cirrhosis and discuss the technical pitfalls and unique advantages associated with various imaging modalities in assessing cirrhotic livers, including noncontrast and contrast-enhanced US, CT, and MRI. Work of the U.S. Government published under an exclusive license with the RSNA. Quiz questions for this article are available in the supplemental material.Keywords
This publication has 63 references indexed in Scilit:
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroenterologyGastroenterology, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Focal nodular hyperplasia or focal nodular hyperplasia‐like lesions of the liver: A special emphasis on diagnosisJournal of Gastroenterology and Hepatology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT?Journal of Cardiovascular Computed Tomography, 2009
- Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerationsClinical Science, 2008
- Focal Nodular Hyperplasia and Hepatic Adenoma: Differentiation with Low-Mechanical-Index Contrast-Enhanced SonographyAmerican Journal of Roentgenology, 2008
- Focal Nodular Hyperplasia-Like Nodules in Alcoholic Liver Cirrhosis: Radiologic-Pathologic CorrelationAmerican Journal of Roentgenology, 2007
- Multicystic fibrolamellar hepatocellular carcinoma CT appearanceClinical Imaging, 1993
- Cystic Hepatocellular CarcinomaJournal of Computer Assisted Tomography, 1991